Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Warts 1Papillomavirus Infections 1High Grade Anal Canal Intraepithelial Neoplasia 1Condylomata Acuminata 1Cancer Survivor 1

Interventions

Cyclophosphamide 548pembrolizumab 384Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05087849 2025-10-02

Intralesional HPV Vaccine for Condylomata

University of California, San Francisco

Phase 1/2 Completed
2 enrolled 7 charts

Condylomata Acuminata, Warts

NCT01824537 2025-03-19

TRAP-HPV

McGill University

Phase 4 Completed
372 enrolled 12 charts

Papillomavirus Infections

NCT03051516 2024-02-28

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Fred Hutchinson Cancer Center

Phase 4 Terminated
188 enrolled 13 charts
GastrointestinalGynecologic

High Grade Anal Canal Intraepithelial Neoplasia

NCT01492582 2021-10-27

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

University of Alabama at Birmingham

Phase 2 Completed
1,499 enrolled 11 charts

Cancer Survivor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡